Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.
Huang
W-C
WC
Chen
W-L
WL
Tsai
Y-Y
YY
Chiang
C-C
CC
Lin
J-M
JM
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000188:drug therapy*; D002908:Chronic Disease; D006801:Humans; D008297:Male
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab